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ABSTRACT 
This research aims to uncover personality traits that affect type II diabetics’ intentions to 
use wearable technologies. Survey data of 321 responses were used for data analysis to 
measure results. Data was analyzed using SPSS software to determine the effects of 
individual traits on current usage and purchase intentions of wearable technologies 
explored in the research. The individual traits studied were involvement, impulsivity, and 
self-consciousness. Smartwatches, smart socks, insulin pumps, and continuous glucose 
monitors were the wearables studied in this research. Results found that involvement has 
an impact on future purchase intentions of wearable technologies. However, impulsivity 
has partial statistical support to have an impact on current usage and future purchase 
intentions in regards to wearables. Finally, self-consciousness was found to have no 
significant impact on current usage and future purchase intentions of technologies.  
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Chapter 1  
INTRODUCTION 
Introduction 
 
Overall Purpose 
 
Wearable technology is a rapidly growing industry that has paved its way to 
intersect with other fields, such as mining and oil refineries, manufacturing and 
production, and preventative health care measures. With each innovative wearable, the 
key is to eventually maneuver through multiple industrial sectors to achieve its maximum 
efficiency and optimization. The potential for wearables is accelerating for various 
purposes; however, the industry with the most potential is healthcare for remote patient 
monitoring, accessible health knowledge, and synchronal electronic medical records 
(Joszt). Remote patient monitoring can allow the users and physicians to effectively 
manage patients’ health through manual or dynamic input of data and alerts or 
notifications of impending health risks. My research focuses on wearable technologies 
used by patients with type II diabetes, which is a relatively untapped research topic. 
Many previous studies discussed in the literature are based upon the technology 
acceptance model (TAM). Most of the existing literature has focused on financial access 
to wearables or personality traits, such as self-awareness, often using the TAM to predict 
these effects (Less 2003). My research will differ and add to this knowledge by 
measuring each individual’s self-consciousness, involvement in healthcare, and 
impulsivity to determine one’s likelihood to use various wearable technologies.  
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The technology acceptance model (TAM) bases its premise upon perceived 
usefulness and perceived ease of use, indicating prospective users of technology do not 
consider other factors (Davis 1986). However, analytical studies discussed in this 
research indicate that consumer adoption of wearables are impacted by personal thoughts 
and self-awareness of using such devices. Therefore, this paper, instead primarily focuses 
on the personality traits of individuals who may potentially affect their intentions to use 
wearable technologies to monitor their diabetes. The personality traits explored in this 
research project include involvement, impulsiveness, risk aversion, and self-
consciousness.  
What Is Wearable Technology 
Wearable technology helps information harmoniously flow from the technology 
to the mobile application (Godfrey et. al 2018). With this feature, users’ conditions are 
monitored at all times, and when necessary, the user receives a notification, showing the 
dynamic capabilities of wearable technologies in healthcare (Godfrey et. al 2018). These 
devices use sensors to gather information about body movement and current health 
conditions, such as total steps for the day or current heart rate (Lee and Lee 2018). 
Portable technology does not utilize any secondary support, rather sensors in the 
technology are essentially in some form attached to the human body, be it through direct 
touch such as smartwatches or clothing such as smart shirts (Gaff 2015).  
Remote technology has the ability to go beyond its role as a mobile actor where 
the user wearing technology is the actor collecting solar energy or detecting the 
surrounding environment air quality (Mardonova and Choi 2018). Smart garments are a 
sector of this rising industry that are slowly progressing in comparison to other smart 
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technologies, such as watches and glasses (“Smart Clothing and Body Sensors”). Smart 
clothing is currently being tested for possible use within professional sports leagues, such 
as Major League Baseball, in order to measure and maximize player performance 
(Leung). These wearables collect biomechanical and physiological data that is then 
monitored and analyzed by teams’ research and development departments in order to 
optimize player potential while also maintaining a player’s mental and physical health 
(Leung).  
Industry Background 
For the entire wearable revenue in 2018, diabetes provided 31.8%, the second 
largest revenue, with congestive heart failure being first at 34.2% (Curran 2018). In 
consideration of all types of wearable technologies, smartwatches are arguably the most 
popular as they account for 52% of the global wearable market share (Tilley 2016). Of all 
smartwatch users, 33% utilize this technology to track and monitor personal fitness levels 
to ensure they achieve specific goals (Fox, Duggan 2014). Perhaps the most popular 
smart technology is the Apple watch which provides haptic feedback -- vibrates to give 
alerts to wearers such as “stand up” or “take more steps” -- and holds the user 
accountable for his or her health (Chowdhry 2018). Wearable technologies can be 
utilized throughout the entire healthcare spectrum from clinical trials to remote 
monitoring. Also, the portable devices can help clinical trials slowly become affordable 
and more accurate as patients wear technology with accountability measures to ensure 
optimal success of the trial. Remote patient monitoring can reduce time and money 
because as patients monitor themselves more, the need for in-person visits decreases 
(Curran 2018). A recent Blue Cross Blue Shield study acknowledges that wearables are 
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expected to decrease hospital costs by 16% in the next five years (Anthem 2017). Simply 
put, these devices provide many benefits and ought to be utilized to their full capacity. 
Why Wearables Are Important 
Wearables are important for use in health care because consumers can use these 
devices to help maintain their health as the physician recommends. Of all individuals 
diagnosed with diabetes, 90-95% have type II diabetes (Berry 2018). Because many 
diabetics often have other health issues that stem from diabetes, it’s important to find new 
ways to help better one’s health status. The intersection between diabetes and wearable 
technology is intriguing as the potential for technology to effectively monitor and prevent 
severe risks is growing rapidly. Wearable technologies strongly engage in the Internet of 
Things (IoT), which refers to storing data from wearables and mobile applications, as the 
growth of technology connects with previously existing servers and other sensors (P. 
Kumari et. al 2017). The alerts, notifications, and dynamic qualities of wearable 
technologies allow them to serve as security checkpoints while connecting doctors and 
patients in and outside the clinic. Extreme value lies in consistently bettering the network 
of devices that depend on personalizing services, detecting analytical patterns, processing 
information at remote locations, and motivating users to achieve specific goals. The IoT 
allows clinicians immense access into the habitual actions of their patients where they 
can remotely monitor patient health in an effective manner (P. Kumari et. al 2017). Most 
of the wearable devices connect to a user interface through an application that can be 
accessed by a smartphone, tablet, or desktop computer (Al-Ozairi 2018). These 
applications allow users to view and analyze their data and post updates on personal 
social media accounts to share information with their circles. 
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Other Health Issues Impacted 
The most popular use of wearable technologies are through fitness trackers, but 
technologies can serve a variety of health purposes such as monitoring sleep cycles or 
optimizing one’s physical health. Aside from the Fitbit Charge HR, other wearables such 
as Jawbone UP3 and Misfit Shine detect light and heavy sleep cycles, alert during light 
sleep cycles, and measure other health vitals (“New Wearable Sleep Trackers”). Also on 
the rise are mentally stabilizing applications that connect to wearable technology -- Muse 
headband for proper meditation, Gymwatch for effective exercising, and PIP for stress 
reduction.  
The growth of technology in healthcare is rapid and innovative with new apps 
created by the second. The sensors in the wearable technologies have the power to 
revolutionize the field of healthcare fiscally, patient health physically, and overall better 
the healthcare industry.  
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Chapter 2 
LITERATURE REVIEW 
2.1 Health Involvement and Technology - Current Use and Purchase Intentions 
Active participation in one’s diagnosis can help an individual better understand 
and monitor his or her health conditions. Remaining actively involved as a patient helps 
doctors better understand the troubles one faces. Technology, in essence, serves to bridge 
that gap when patients are not in the clinical room for examination.  
An observation study was conducted to determine if wearables can improve the 
quality of life of those with Parkinson’s disease. Parkinson’s disease, a neurodegenerative 
disorder, may cause individuals to experience stiff muscles and limbs, muscle tremors, or 
bradykinesia (“What Is Parkinson's?” 2019). The simplest wearables that were first 
created featured the ability to measure physical activity, which was key in this study. 
During the course of the study, those with Parkinson’s disease were more active in 
comparison to their typical sedentary lifestyle; for example, their walking time decreased 
(Van Uem 2016). Further analysis noted three factors that limit participation: negative 
experiences with social withdrawal due to feeling embarrassed or embarrassing someone 
else; the unpredictability of motor, as well as non-motor symptoms; loss of energy and 
strength, which is at least partly reflecting fatigue (Van Uem 2016). As noted in the 
study, further research might include how to determine how patients with Parkinson’s 
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disease can exercise full autonomy to improve quality of life (Van Uem 2016). Because it 
is difficult to explain the relation between autonomic irregularities and a poor health-
related quality of life (HRQoL), wearables could serve to bridge the communication gap 
(Van Uem 2016).  
Two particular individuals further note the possible positive implications 
wearables can have on an individual’s Parkinson’s Disease (PD) diagnosis. A male, who 
is forty-seven years old, has had PD for nineteen years. He mentions his quality of life 
could be improved if he had the ability to self-interpret his health through measurements, 
which could provide him the opportunity to adapt his lifestyle as needed. Another male of 
the same age has been diagnosed with PD for thirteen years. He notes that having an on-
going diagnostic would be beneficial as well as receiving health condition updates, 
recommendations based on current status, and medication reminders to his mobile device 
(Van Uem 2016). 
Participants in this study were actively involved in determining what impact, if 
any, technologies served in helping to effectively monitor his or her diagnosis. Typically, 
patient involvement allows for him or her to better constantly monitor personal health 
conditions. With serious illnesses, patients are likely to sometimes feel depressed and 
hence, uninvolved, in their personal health conditions.  
Monitoring and treating a health issue is crucial; therefore, staying involved with 
personal health can help better the outcome. However, with diagnosis of chronic or 
serious illnesses, severe and strong emotions are attached to one’s mind at the time of 
diagnosis, which may cause one to not strictly adhere to one’s care routine of one’s 
health.  
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Self-management education refers to the systematic intervention that includes 
active participation of patients in self-monitoring and/or decision-making and equipping 
diabetic patients with necessary knowledge and skills to maintain self-care, handle crises, 
and enable crucial lifestyle changes. Within a typical year, patients with type II diabetes 
who miss more than 30% of their scheduled appointments are likely to have a higher 
HbA1c level by 7%, in comparison to those who adhere to their proper health care 
regimen (Al-Ozairi 2018). A study that included 752 diabetic patients showed that proper 
physician-patient communication increased patient’s physical activity, proper self-care 
adherence, and foot care (Kumah 2018). Of all studies examined in a secondary literature 
review, five measured the effect of self-management on mental health, and all reported 
better mental health levels with introduction and use of the self-management model for 
his or her diagnosis (Kumah 2018).  
As discussed, wearables were used to help monitor patients with PD and type II 
diabetes. Through both critical analyses, we see that patient involvement in personal 
health can provide positive benefits. Because these revolutionary technologies can hold 
patients accountable and involved, it’s important to consider other possible facets of use 
with wearables. 
With this research, I hypothesize the following:  
H1. As consumers’ involvement with diabetes as a personal health issue 
increases, the likelihood that they use wearable technology increases. 
H2. As consumers’ involvement with diabetes as a personal health issue 
increases, their intentions to purchase wearable technology in the future increases.  
2.2 Impulsivity and Technology - Current Use and Purchase Intentions  
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Impulsive decision-making refers to displaying behavior where the individual has 
not given forethought or consideration of possible implications of his or her decisions 
(“Meaning of Impulsive” 2019). Receiving and gathering information to confirm reasons 
to make a purchase leads to faster decision-making and impulse purchasing (Lurie 2017). 
As an individual’s impulsivity increases in regards to decision-making, he or she is also 
likely to use mobile technology more often (Lurie 2017). Once an impulsive individual is 
online, he or she experiences unplanned purchase behavior, eventually creating 
psychological impulsivity (Huang 2012). A study found that internet addiction leads to 
impulsive buying online, which affects mental instability (Chen 2016). Further studies 
show that there are undeniable parallels between internet and gambling addicts in terms 
of their impulsive decision-making (Chen 2016). Consumers who constantly surf the 
internet are more likely to exhibit dysfunctional and uncontrollable impulsive behaviors 
(Chen 2016).  
For an example, consider a study that was conducted to determine if influence or 
impulse was the main driver behind an individual’s actions (Gilman 2014). The sample 
consisted of fifty-one “well-functioning college students from near-optimal 
environments” who were all medically healthy (Gilman et. al 2014). Researchers 
observed various environments to measure impulsive cues. The following situations were 
observed that eventually proved impulse was a stronger cue for their decisions rather than 
the influence of others: choosing healthier snacks even though he or she is not familiar 
with the products because of the reference group, physical activity, alcohol intake 
(Gilman et. al 2014). “Generally, peoples’ perceptions of others’ behavior have been 
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found to be strong predictors of behavior, and this is especially true when the ‘others’ are 
thought of as a peer group” (Gilman et. al 2014).  
Impulsivity also plays a role in childhood and adolescent obesity (Field 2013). 
Obese individuals are more impulsive in comparison to those of “healthy” weight 
according to their height and BMI (Fields 2013). The behavior behind online impulsive 
decision-making and purchasing, reference group cues, and eating habits are tied together 
on the premise of engaging in behaviors without forethought of possible consequences. 
With consumer behavior being unpredictable, they might be inclined to purchase items 
that are trendy amongst their reference groups and opinion leaders. The reference group 
cues are also strongly aligned with impulsive eating as discussed in the studies because 
one’s behavior might be dictated by the other’s habits.  
With this research, I hypothesize the following:  
H3. As consumers’ impulsivity increases, the likelihood that they use wearable 
technology increases. 
H4. As consumers’ impulsivity increases, their intentions to purchase wearable 
technology in the future increases.  
2.3 Self-Consciousness and Technology - Current Use and Purchase Intentions 
Self-consciousness refers to “being aware of oneself as an individual; 
uncomfortably conscious of oneself as an object of the observation of others” (“Self-
Consciousness” 2019). In efforts to raise self-esteem, we, as individuals, tend to seek 
artifacts or fashions items, such as personal digital technologies, to express our 
personalities (Shinohara 2016). A 2016 study to measure self-consciousness while 
wearing wearables was conducted with a sample of 147 participants. These participants 
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had various disabilities (blind, hard of hearing, deaf, visually impaired), and each 
participant was asked to log if they felt self-conscious or self-confident while wearing the 
wearable technology (Shinohara 2016). When first given assistive technologies, many felt 
self-conscious at their inability to understand and properly utilize such technologies for 
their benefit (Shinohara 2016). However, as familiarity with the technology increased, 
self-consciousness decreased (Shinohara 2016). In contrast, when he or she directly 
interacts with a more tech savvy individual, he or she becomes self-conscious (Shinohara 
2016).  
Furthermore, results indicated that individuals who received unwanted attention 
wearing or utilizing personal technologies possessed negative feelings and mindsets 
(Shinohara 2016). These participants explained that they experienced heightened negative 
feelings due to social settings, regardless if the they were alone or within a group 
(Shinohara 2016). The results of the study support the notion that self-consciousness and 
self-confidence create a social feedback loop, which heavily impacts an individual’s 
behavioristic decisions (Shinohara 2016).   
Because self-consciousness can impact self-management habits, another study 
was examined to determine if self-awareness played a role in self-management of health. 
The study included 105 type II diabetic participants, and each of their blood sugar levels 
was measured over the course of a week, six months, and twelve months (Lane 2000). 
Those involved also took the NEO personality inventory, which asked for each 
participant’s age, sex, race, length of diabetes diagnosis, current medications, and, if any, 
experimental treatment (Lane 2000). In this study, individuals who had poorer control of 
their glycemic levels also experienced low self-consciousness levels as well as increased 
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anxiety and depression. (Lane 2000). “Stronger tendencies to worry and experience other 
negative emotions may provide increased motivation for a patient with diabetes to follow 
the necessary self-care regimen and achieve a better clinical outcome,” (Lane 2000).  
Depression is increasing with the growing number of diabetes cases. Those who 
are depressed are less likely to care for themselves, manage their blood sugar properly, 
and live for a shorter amount of time (Al-Ozairi 2018). Type II diabetes is a burden on 
patients that is growing, nationally, at a fast rate, with over 100 million diabetic cases 
(“CDC Newsroom” 2017). Therefore, there comes a time to explore new ways to monitor 
patients that is easier for both the clinician and patient; hence, the idea of e-monitoring 
comes to mind. E-health refers to the use of electronic information with the internet in 
efforts to better one’s personal health care. With this platform, patients have the 
opportunity to receive and access an abundance of health information maintaining 
confidentiality, leaving their home for the clinic, or feeling the public stigma associated 
with diabetes. Due to the immense information and access available to electronic 
information processing, patients can now utilize mobile devices to improve and monitor 
their health issues. As noted by Al-Ozairi in 2018, m-health refers to “the use of mobile 
devices such as phone, for health processes.” The communication exchange has shown to 
be successful in motivating patients to improve their personal health care. As electronic 
commerce has grown into the healthcare sector, more opportunities have risen where 
patients can receive virtual care from clinicians in the luxury of their own home. With 
this innovative method, patients can establish self-care changes that are cheap and 
adaptable.  
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To further display the effects of depression in diabetics, another study was 
analyzed with 864 type II diabetics, all of whom completed a MINI diagnostic interview 
that measured psychological distress and depression (Dooren 2016). The traits were 
measured by the DS14 and Big Five personality questionnaires (Dooren 2016). The DS14 
consists of 14 items that might create negative states, and the Big Five measures 
measures five main personality domains-- extraversion, agreeableness, conscientiousness, 
emotional stability and openness to experience (Dooren 2016). Within the study, it was 
found that type II diabetics were less extraverted, conscientious, agreeable and 
emotionally stable (Dooren 2016). Because these individuals displayed emotions in 
relation to depression and anxiety, they are said to be self-conscious (Dooren 2016). As 
mentioned previously, individuals who are self-conscious are likely to experience 
depression and anxiety, consequently suffering lower quality of mental health.  
In efforts to suppress self-consciousness and feel confident, some individuals seek 
branded goods and services to increase their self-esteem, making them feel less self-
conscious (Machin 2018). Those who share higher self-esteem levels are more likely to 
take better care of their mental and physical health (Machin 2018).  
In short, as individuals wear these devices, others are naturally inclined to look 
towards other individuals. Hence, they become self-consciousness and are wary of using 
such devices, which only grows directly with suffering from depression. 
With this research, I hypothesize the following:  
H5. As consumers’ self-consciousness increases, the likelihood that they use 
wearable technology decreases. 
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H6. As consumers’ self-consciousness increases, their intentions to purchase 
wearable technology in the future decreases. 
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Chapter 3 
SURVEY DESIGN 
3.1 Data Collection and Sample 
To test my hypotheses described in Chapter 2, I developed a survey in Qualtrics, 
administered the survey to a sample of men and women with type II diabetes, all 18 years 
of age or older. The survey vendor that I used was RN/SSI (Research Now), a premier 
survey sampling and data collection company. Boas and Hidalgo (2013) assert that 
Qualtrics is a crowdsourcing software that is recognized as a successful online surveying 
engine founded for academic research and available on the websites of many universities.  
The first step in collecting my data was the creation of the questionnaire in 
Qualtrics. The complete survey is available in Appendix A. Next, I administered the 
online survey to residents in the United States through RN/SSI. From the participants, I 
collected 321 survey responses with 48% from women, 51.1% responses from men, and 
.9% who selected prefer not to answer, all of whom are type II diabetics. The age range 
of these participants varied from 20 to 85 years old. Exactly 24% of the respondents are 
ethnic minorities, consisting of Hispanic or Latino, African-American/Black, and 
Asian/Pacific Islander; however, whites/caucasians formed 74.1% of the overall 
respondents. More than half of the participants received degrees beyond a high school 
education at 55.8% while only .3% of the individuals did not complete their high school 
education/receive their GED. Less than a quarter of the participants are within the 
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$100,000 and above income level, precisely 23.7%. However, 32.7% of participants’ 
income levels are less than $50,000 per year.  
Further analysis of the United States sample showed over half of the participants 
are married and 63.9% have children. A quarter of the survey respondents fall into the 
55-64 age range. Often those who fall within the 45 to 64 years old age range are the 
most diagnosed group for type II diabetes (Cherney 2015). These demographic factors 
are the most common amongst the surveys across various research projects. They allowed 
me to draw further conclusions and analyze what influence, if any, their age, gender, or 
ethnicity had on their usage rates and future purchase intentions. A complete 
demographic summary of the sample is shown in Table 1. 
Demographic Factor % of sample 
Age: 18-24 2.5% 
Age: 25-34 17.8% 
Age: 35-44 17.1% 
Age: 45-54 22% 
Age: 55-64 25.9% 
Age: 65-74 12.4% 
Age: 75 or older 2.4% 
Age: Prefer not to say .3% 
  
Gender: Male 51.1% 
Gender: Female 48% 
Gender: Prefer not to answer .9% 
  
Ethnicity: White/Caucasian 74.1% 
Ethnicity: Hispanic or Latino 8.4% 
Ethnicity: Asian/Pacific Islander 4.1% 
Ethnicity: African-American/Black 11.5% 
Ethnicity: Other 1.9% 
  
Education: Some high school .3% 
Education: High school graduate, or the equivalent 
(GED) 
11.5% 
Education: Some college  22.1% 
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Education: Trade/technical/vocational training 8.4% 
Education: College graduate 37.7% 
Education: Some postgraduate work 1.9% 
Education: Post graduate degree 18.1% 
  
Income: less than 29,999 12.8% 
Income: 30,000-39,999 11.5% 
Income: 40,000-49,999 8.4% 
Income: 50,000-59,999 14.0% 
Income: 60,000-69,999 9.3% 
Income: 70,000-79,999 7.8% 
Income: 80,000-89,999 5.9% 
Income: 90,000-99,999 6.5% 
Income: 100,000 and above 23.7% 
  
Marital Status: Yes 54.8% 
Marital Status: No 45.2% 
  
Kids: Yes 63.9% 
Kids: No 36.1% 
Table 1: Demographics of Survey Respondents 
RN/SSI was used to collect responses from types II diabetics throughout the 
nation because they recruit a representative sample and utilize quality controls, providing 
quality data results for the researcher. Research Now also ensures that participants are 
easily compensated for their time and effort once they have successfully completed the 
survey.  Each participant was paid approximately $3.73 for their time and effort on the 
survey. Midway through the survey, participants completed an attention check and were 
prompted to select a specific answer. If the specified answer was not selected, the 
respondent was automatically rerouted to the end of the survey. The attention check 
served as a quality control to ensure survey data integrity. 
Prior to sending the survey to participants, an IRB application was submitted to 
the University of Mississippi IRB for approval to begin data collection. The University of 
MIssissippi IRB approved the application as exempt under 45 CFR 46.101(b)(#2). The 
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link to complete the survey was sent to the sample described above in an email that 
explained both the survey and the purpose of the study. The body of the email may be 
found in Appendix B.  
The survey began by ensuring the participant was 18 years of age. If the 
participant was not 18 years of age, the survey automatically rerouted him or her to the 
end and did not allow the participant to continue further. After consent, the respondent 
was given an overview of wearable technology and asked if he or she currently used 
wearable technologies to monitor his or her diabetes, and if so, which technologies were 
used.  
The survey examined four types of wearable technologies -- smartwatches, smart 
socks, continuous glucose monitors (CGM), and insulin pumps. These specific 
technologies were chosen because they allow patients to directly access their health, 
provide preventative care, and help management of chronic illnesses (Piwek et. al 2016). 
Generally, diabetic smartwatches measure total distance walked, heart rate, and glucose 
levels of the individual (Draper 2018). Smart socks, a relatively new type of wearable 
technology, can detect foot ulcers, which is often a complication of diabetes (“Diabetic 
Foot Monitoring”). Continuous glucose monitors tracks one’s blood glucose levels at all 
times, so patients are able to take their levels into consideration when making decisions 
about their meals (“Continuous Glucose Monitoring” 2017). The CGM allows for the 
individual to access their health information immediately as well as sync the information 
to a computer or smart device mobile application to gather more insights (“Continuous 
Glucose Monitoring” 2017). Insulin pumps, which are small, computerized technical 
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devices, constantly deliver small dosages of short-acting insulin; the rates are typically 
set with the physician first (Tamboli 2019).  
 Before answering questions specific to each technology, the survey displayed an 
overview of the technology and its prospective uses for a diabetes diagnosis. Participants 
also answered several behavioristic and demographic questions for each technology. 
These  are discussed in section 4.2. 
3.2 Measuring Independent Variables 
The hypotheses primarily focus on the social aspects of an individual’s 
personality, in terms of how it affects their current usage and purchase intentions of 
wearable technologies. The independent variables for the study were the measured 
personality aspects, including general involvement, impulsivity, and self-consciousness. 
These three variables were measured using a seven-point Likert scale where 1 = strongly 
disagree and 7 = strongly agree. Two statements were included for each personality trait. 
Each independent variable was interpreted by computing the average value of both 
statements. The statements used for involvement (r = .47, p < .001), impulsivity (r = .60, 
p < .001), and self-consciousness (r = .37, p < .001) displayed data that proved the 
statements were not properly correlated to provide significant data results.  
 Involvement 
● Diabetes is a health issue that is personally relevant to me. 
● I am very involved with diabetes as a health issue. 
Impulsivity  
● I buy things without thinking. 
● I consider myself an impulse purchaser. 
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Self-consciousness  
● I’m self-conscious about the way I look. 
● I’m concerned about what other people think of me. 
 
 
3.3 Measuring Dependent Variables 
3.3.1 Purchase Intentions 
As previously mentioned, three hypotheses measure each personality trait with 
current usage and the other three hypotheses measure each personality trait with purchase 
intentions. Two dependent variables were measured in the survey: current usage and 
purchase intentions. However, only for purchase intentions, were there multiple 
statements used to measure respondents’ likeliness to purchase a specified wearable 
technology. The value of purchase intentions, per technology, was measured and 
interpreted by computing the average value of both statements for each type of wearable 
technology discussed in the study. The questions that were asked showed strong 
correlation (smartwatch: r = .72; p < .001; smart socks: r = .78; p < .001; CGM: r = .71, p 
< .001; insulin pump: r = .78, p < .001). These three variables were measured using a 
seven-point Likert scale where 1 = very unlikely or not probable, respective to their 
questions, and 7 = very likely or very probable, also depending on the question asked.  
 Smartwatch 
● How likely would you be to use smartwatches in the future? 
● How probable would you be to use smartwatches in the future? 
 Smart socks 
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● How likely would you be to use smart socks in the future? 
● How probable would you be to use smart sock in the future? 
 Continuous glucose monitors (CGM) 
● How likely would you be to use continuous glucose monitors in the 
future? 
● How probable would you be to use continuous glucose monitors in the 
future? 
 
 Insulin pumps 
● How likely would you be to use insulin pumps in the future? 
● How probable would you be to use insulin pumps in the future? 
3.3.2 Current Usage                                                                                                                         
 The question in the survey used to measure current usage is, “Do you currently 
use [wearable technology] to monitor your diabetes?” Because this was a dichotomous 
question, a response as “yes” was equal to 1 whereas a “no” response was coded to 2. 
The most currently used technology amongst type II diabetics are smartwatches at 18.7% 
whereas the least popular are smart socks at 92.5%. A complete table showing current 
usage of the four wearables explored in the survey can be found in Table 2. 
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 Currently DO use Currently DO NOT use 
Smartwatches 18.7% 81.3% 
Smart socks 7.5% 92.5% 
Continuous Glucose Monitors (CGM) 15.3% 84.7% 
Insulin Pumps 14.3% 85.7% 
Table 2: Current Usage Rates by Wearable Type 
3.3 Analytical Procedure Description 
 To analyze results, I used the statistical software SPSS to conduct descriptive 
tests, frequencies tests, and regressions - binary and logistic. The current version of SPSS 
available to students, faculty, and staff at the University of Mississippi is version 25; 
therefore, SPSS 25 was used. In order to measure the effect on the dependent variables, 
current usage and purchasing intentions, I conducted linear regressions within SPSS to 
find relationships with various personality traits. Linear regression tests allow me to look 
at the dependent variable as continuous and dichotomous. The regressions showed the 
relationship between the independent and dependent variables, which were either positive 
or negative and showed varying relationship strengths. The results of the linear 
regressions are presented in Chapter 4, and these results provide a more thorough 
examination of the relationships between the independent variables (involvement, 
impulsivity, risk aversion, and self-consciousness) and the dependent variables (current 
usage and purchase intentions). 
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Chapter 4  
RESULTS 
In this section, the results from binary and linear regressions are given and 
interpreted for social and external variables.  
4.1 Analysis of Social Variables 
Binary regression results revealed that involvement did not have a significant 
effect on whether respondents currently use a smartwatch (B = -.063, S.E. = .066, p = 
.341), smart socks (B = -.051, S.E. = .098, p = .599), continuous glucose monitors (B = -
.021, S.E. = .071, p = .763), or insulin pumps (B = -.026, S.E. = .073, p = .719). Thus, H1 
is not supported. 
 B SE significance 
Smartwatch -.063 .066 .341 
Smart Socks -.051 .098 .599 
Continuous Glucose 
Monitors 
-.021 .071 .763 
Insulin Pumps -.026 .073 .719 
Table 3: Effects of Involvement on Likelihood of Current Usage 
Linear regression results revealed that there was a significant positive effect of 
involvement on respondents' purchase intentions for smartwatches (B = .246, t = 4.218, 
S.E. = .058, and p < .001), continuous glucose monitors (B = .245, t = 4.716, S.E. = .052, 
and p < .001), and insulin pumps (B = .220, t = 4.491, S.E. = .049, and p < .001), such 
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that intentions increased as involvement increased. Involvement also proved to be 
somewhat significant on participants’ intentions to purchase smart socks (B = .110, t = 
2.169, S.E. = .051, and p = .031). Therefore, H2 is fully supported. 
 unstandardized 
B 
t  Coefficient std. 
error 
significance 
Smartwatches .246 4.218 .058 .000 
Smart socks .110 2.169 .051 .031 
Continuous 
glucose monitors 
(CGM)  
.245 4.716 .052 .000 
Insulin Pumps .220 4.491 .049 .000 
Table 4: Effects of Involvement on Purchase Intentions 
Binary regression results revealed that impulsivity had a significant effect on 
whether respondents currently use a smartwatch (B = -.305, S.E. = .105, p = .004) and 
smart socks (B = -.339, S.E. = .151, p = .025), such that their usage likelihood increases 
as their impulsivity increases. However, regression results showed that impulsivity did 
not have an effect on whether respondents currently use continuous glucose monitors (B 
= -.130, S.E. = .109, p = .235) and insulin pumps (B = -.154, S.E. = .112, p = .170), 
which shows that H3 is partially supported - only by smartwatches and smart socks.  
 B SE significance 
Smartwatches -.305 .105 .004 
Smart Socks -.339 .151 .025 
Continuous Glucose 
Monitors 
-.130 .109 .235 
Insulin Pumps -.154 .112 .170 
Table 5: Effects of Impulsivity on Likelihood of Current Usage 
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Linear regression results revealed that there was a significant positive effect of 
impulsivity on respondents' purchase intentions for continuous glucose monitors (B = 
.242, t = 3.118, S.E. = .078, and p = .002) and insulin pumps (B = .201, t = 2.747, S.E. = 
.073, and p = .006), such that intentions increased as impulsivity increased. However, 
impulsivity proved to not have a significant impact on survey participants’ intentions to 
purchase smartwatches (B = .078, t = .922, S.E. = .085, p = .357) and smart socks (B = 
.059, t = .800, S.E. = .078, p =.424. Hence, H4 is partially supported by continuous 
glucose monitors and insulin pumps. 
 unstandardized 
B 
t  Coefficients std. 
error 
significance 
Smartwatches .078 .922 .085 .357 
Smart socks .059 .800 .074 .424 
Continuous 
glucose monitors 
(CGM)  
.242 3.118 .078 .002 
Insulin Pumps .201 2.747 .073 .006 
Table 6: Effects of Impulsivity on Purchase Intentions 
Binary regression results revealed that self-consciousness did not have a 
significant effect on whether respondents currently use a smartwatch (B = -.116, S.E. = 
.100, p = .245), smart socks (B = -.042, S.E. = .131, p = .748), continuous glucose 
monitors (B = -.034, S.E. = .101, p = .738), or insulin pumps (B = .078, S.E. = .101, p = 
.439). Thus, H5 is not supported. 
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 B SE significance 
Smartwatches -.116 .100 .245 
Smart Socks -.042 .131 .748 
Continuous Glucose 
Monitors 
-.034 .101 .738 
Insulin Pumps .078 .101 .439 
Table 7: Effects of Self-Consciousness on Likelihood of Current Usage 
Linear regression results revealed that there was a significant positive effect of 
self-consciousness on respondents' purchase intentions for continuous glucose monitors 
(B = 2.91, t = 4.191, S.E. = .069, and p < .001) and insulin pumps (B = .424, t = 6.777, 
S.E. = .063, and p < .001), such that intentions increased as self-consciousness increased. 
Self-consciousness also proved to be significant on participants’ intentions to purchase 
smartwatches (B = .170, t = 2.165, S.E. = .079, and p = .031) and smart socks 
smartwatches (B = .203, t = 2.964, S.E. = .068, and p = .003). However, as the data 
indicates as self-consciousness increased, self-consciousness also increase; this is the 
opposite of the hypothesis. Therefore, H6 is not supported.  
 unstandardized 
B 
t  Coefficients std. 
error 
significance 
Smartwatches .170 2.165 .079 .031 
Smart socks .203 2.964 .068 .003 
Continuous 
glucose monitors 
(CGM)  
2.91 4.191 .069 .000 
Insulin Pumps .424 6.777 .063 .000 
Table 8: Effects of Self-Consciousness on Purchase Intentions 
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Chapter 5  
 GENERAL DISCUSSION  
 In the first section of this chapter, I will summarize and further analyze the results 
mentioned in Chapter 4. I will also interpret these results and discuss their correlation 
with the hypothetical frameworks mentioned in the introduction and literature review. 
Then, I will discuss the limitations and obstacles experienced throughout the process of 
conducting research for and writing this work. Finally in the last section, I explain the 
future implications of this thesis for future research on wearable technologies for type II 
diabetics. 
The prevalence of diabetes is ever growing due to the massive increase in cases 
since 1980 (Chatterjee, Khunti, Davies 2017). On a global scale, the number of type II 
diabetes cases have increased by 60% in women whereas they have doubled for men 
(Hackethal 2016). Diabetics must not only be wary of their glucose levels but also they 
must be wary of their bone health because type II diabetics are at higher risk for bone 
fractures (Leslie 2012). In addition to bone fractures, diabetics are more prone to 
cardiovascular and kidney disease, neuropathy, and blindness (Deshpande, Harris-
Haynes, Schootman 2008). Moreover, type II diabetics’ mortality rate, in comparison to 
non-diabetics, is 15% higher, further proving the massive effect this chronic illness can 
cause upon individuals (Chatterjee, Khunti, Davies 2017). Diabetes was the sixth leading 
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cause of death in 2002, with more than 70,000 cases stating diabetes as the underlying 
reason for death (Deshpande, Harris-Haynes, Schootman 2008). 
Type II diabetes can be prevented if individuals manage their physical health as 
well as glucose levels (Chatterjee, Khunti, Davies 2017). Both primary concerns can be 
alleviated with use of wearable technologies such as smartwatches, which was mentioned 
previously in this article. The most basic diabetic smartwatches have the ability to track 
how far an individual walks, progression of heart rates, and measurement of glucose 
levels (Hosseini and Tabasi 2015). Smartwatches have been introduced within the 
wearable industry for years; however, a newer type of wearable technology studied in this 
research are smart socks. Smart socks detect pressure changes in the foot and foot ulcers, 
which are both likely for diabetics (Perrier et. al 2014). Insulin pumps and continuous 
glucose monitors are both wearable technologies used to monitor and essentially better 
manage one’s type II diabetes diagnosis. Because type II diabetics require larger amounts 
of insulin, individuals may not be able to gain long term control of their insulin levels, an 
issue the insulin pump alleviates with the bolus dosage of insulin (Bode 2010). In a study 
of type II diabetics who have been diagnosed from two to nineteen years, 90% of the 
individuals were compliant in using their CGM device and had reduced HbA1c levels 
(Taylor, Thompson, Brinkworth 2018). 
 This research aims to uncover type II diabetics’ possible intentions to adopt 
wearable technologies in efforts to better monitor and manage their diagnoses. According 
to data results, H1 and H5 were not supported, which shows that involvement and self-
consciousness had no impact on likelihood of current usage. However, involvement and 
self-consciousness heavily impact future purchase intentions of wearable technologies, 
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which prove that H2 and H6 are fully supported. Lastly, impulsivity had partial a effect 
on likelihood of current usage as well as future purchase intentions; therefore, H3 and H4 
are partially supported. 
 The hypotheses for purchase intentions are fully supported when considering 
involvement and self-consciousness. The larger t value was shown along self-
consciousness, and a greater t value indicates a stronger response for that specified 
variable. Following, consumers’ involvement with diabetes as a health issue was a 
stronger hypothesis, according to data results, than consumers’ impulsivity. Simply put, 
the order of importance of personality traits to the average type II diabetic individual is 
self-consciousness, involvement, and impulsivity.  
5.1 Theoretical Implications 
 Previous academic literature primarily considers access and perceived use of 
wearable technologies. In contrast, my research takes a deeper look into the personality 
and mindset of the type II diabetic. While perceived use may account for some adoption 
of technologies, some studies do not take into account why some find technologies harder 
or easier to use, and numerous traits such as involvement can impact that decision. 
Impulsive consumers are often the first that come to a marketer’s mind; however, 
involvement and self-consciousness may be the first traits that a health scientist will 
immediately think of.  
5.2 Public Health Implications 
In the realm of public health, epidemiology is a premise into understanding how 
diseases affect different groups of individuals and how they can impact the population 
overall. Type II diabetes impacts millions of individuals, and their disease is a precursor 
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to other illnesses as mentioned previously. Therefore, the importance in determining 
better methods to manage a type II diabetes diagnosis is vital. While continuous glucose 
monitors and insulin pumps are popular technologies used in monitoring diagnoses, 
individuals and health professionals should promote and acknowledge the positive 
implications in using smartwatches and smart socks. With the results of this research, 
practitioners ought to consider the purchase intention differences amongst different ethnic 
groups. For example, because African-Americans are more prone to being diagnosed 
with type II diabetes than Caucasians, African-Americans might have higher purchase 
intentions than other groups. In the study, participants were asked to acknowledge other 
health issues they have such as neuropathy or hypertension. Public health practitioners 
ought to elaborate on these results by using a graphic ratings scale. Specifically, it would 
be beneficial for the researcher to provide a graphic ratings scale for each of the five most 
common illnesses caused as a results of diabetes. In doing such, a public health 
practitioner might have more insight to determine the full impact of diabetes on an 
individual’s health, giving a clearer picture of their diagnosis progression.  
5.3 Overall Implications  
 As aforementioned, the technology acceptance model (TAM) states that perceived 
usefulness and ease of use are two strong determinants in the adoption of technology by 
consumers (Davis 1986). However, the respondents for this survey were given options 
from perceived usefulness to personality traits to effectively determine the role they 
played in technology adoption. Because the data does not show that perceived usefulness 
and ease of use affect current usage and purchase intentions, it is assumed the premises of 
the TAM are not as pertinent to today’s modernized society. However, the self-
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management model discusses that active monitoring of one’s personal health conditions. 
As mentioned in the literature review studies, the SME was found to be beneficial in 
improving the health conditions and quality of life for Type II diabetics. Further, H2, 
which measures involvement and purchase intentions, is the second strongest hypothesis 
in the data analysis. This proves the shift that is occuring from considering use of 
technology to personality traits affecting use of technologies.  
 Moreover, much discussion of technology adoption is based upon the practicality 
or cost of such devices. However, as shown in this survey data analysis, it is clearly seen, 
through extremely strong data support, that personality traits are the biggest drivers 
behind adoption of technology.  
5.3 Limitations and Future Research  
 My research was not without flaws, which I will explain to help future researchers 
within any realm of this topic. For the questions in regard to age, height, and weight, one 
respondent said “prefer not to say” in the text box provided. A better method of asking 
such questions should be utilized to avoid this situation. Furthermore, only one survey 
vendor and data source was used in analysis, whereas more sources would provide a 
better picture and analyses. Lastly, 24% of the respondents are of ethnic minorities, so a 
rather large portion of the sample are of one ethnicity. Hence, the results might possibly 
be skewed as such.  
 Future research should measure various types of a technology as each 
independent survey of their own. For example, it would be beneficial to describe various 
types of smartwatches for type II diabetics to determine which features are most sought 
after in monitoring and managing a patient’s diagnosis, and the same could be done for 
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smart socks, insulin pumps, and continuous glucose monitors. Furthermore, social 
pressure as a personality trait should be measured in the future. Because many who are 
diagnosed with the same illness tend to confide in one another, they might make 
decisions because others are doing as such. With a type II diabetes diagnosis, a patient 
has a delicate state of mind and can be swayed based on his or her reference group.  
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Appendix A 
SURVEY 
  
Q1 Are you at least 18 years old? 
❍ Yes (1) 
❍ No (2) 
  
Skip To: End of Survey If Are you at least 18 years old? = No 
  
Q2 Do you have Type 2 Diabetes? 
❍ Yes (1) 
❍ No (2) 
  
Skip To: End of Survey If Do you have Type 2 Diabetes? = No  
  
Q3 
Consent to Participate in Research 
Title: Individual Perceptions of Wearable Technology      
Investigator                                                                        Faculty Sponsor   
Ashna Sethi                                                                     Christopher Newman, Ph.D.   
Department of Marketing                                                Department of Marketing   
238 Holman Hall                                                             238 Holman Hall   
University of Mississippi                                                 University of Mississippi   
University, MS 38677                                                      University, MS 38677   
(601) 622-5053                                                                 (662) 915-5820 
The purpose of this study  The purpose of this research is to determine how diabetics 
use, if they do, technology. We want to know how diabetics use wearable technology to 
assist their diabetic diagnosis in enhancing their quality of life. You will take a survey 
that asks about your current and future intentions to use technology to improve your 
quality of life as a diabetic. The latter part of the survey are demographics--age, 
education, and income. You will not be asked for your name or any other identifying 
information.      
Costs and Payments    
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This survey will take a total of 15 minutes or less. 
 
Risks and Benefits   
There are no associated risks with taking this survey. In addition to contributing to our 
knowledge about consumer behavior, you will be given approximately 4 dollars’ worth of 
points towards your account for successful completion of the survey.  
 
Confidentiality   
Your name will be in no way associated with your responses.  The only information that 
will be on your survey will be some general demographic information and the unique yet 
anonymous identifier you choose to give yourself for the sole purpose of payment. 
Therefore, we do not believe that you can be identified from any of your responses.      
 
Right to Withdraw   
You do not have to take part in this study. Whether or not you choose to participate or to 
withdraw will not cause you to lose any benefits to which you are entitled.  Inducements, 
if any, will be prorated based on the amount of time you spent taking the survey. The 
researchers may terminate your participation in the study without regard to your consent 
and for any reason, such as protecting your safety and protecting the integrity of the 
research data.  If the researcher terminates your participation, any inducements to 
participate will be prorated based on the amount of time you spent on the study.      
 
IRB Approval   
This study has been reviewed by The University of Mississippi’s Institutional Review 
Board (IRB).  If you have any questions, concerns, or reports regarding your rights as a 
participant of research, please contact the IRB at (662) 915-7482 or irb@olemiss.edu. 
 
Statement of Consent   
I have read and understand the above information. By completing the survey I consent to 
participate in this study.   I have read the above information. I have been given a copy of 
this form. I have had an opportunity to ask questions, and I have received answers. I 
consent to participate in the study. Furthermore, I also affirm that the experimenter 
explained the study to me and told me about the study’s risks as well as my right to refuse 
to participate and to withdraw.  
Page Break   
 
Q4 
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Please make sure you carefully read and understand  the definition below before 
proceeding with the survey. 
Wearable technologies are directly worn as clothing or accessories that track health data 
and/or vital signs and location that allow the user to control bodily functions consciously. 
Wearables contain sensors that give the user access to a wide range of information from 
heart rate to number of steps completed in a day. 
 
Different types of wearables support different activities from maintaining a healthy 
fitness plan to preventing a negative event. Information consistently flows from the 
device to the user, allowing the user to constantly monitor his or her health on the device. 
This has helped wearables gain popularity worldwide. 
  
 Q5 Have you ever used wearable technologies for diabetes? 
❍ Yes (1) 
❍ No (2) 
  
Display This Question: 
If Have you ever used wearable technologies for diabetes? = Yes 
  
Q5.1 Which wearable technologies have you used to monitor and/or control your 
condition? 
________________________________________________________________ 
  
Page Break   
Q6 
DIRECTIONS:  
You are going to be given a brief description of 4 different wearable technologies. 
You'll then be asked a series of questions about each. While the questions for each 
technology are the same, it is important that you answer them based only on the 
specific technology that is being asked about.  
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Q7 
DIABETIC SMARTWATCHES 
 Diabetic smartwatches measure glucose levels painlessly through a sensor and do 
not require a blood sample. The watch measures steps taken and calories burned in 
addition to offering unlimited glucose measures in a 30-day period. It even sends 
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you reminders when you haven't measured your glucose levels in a certain amount 
of time.  
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Q8 
DIRECTIONS:  
Please consider the following questions about diabetic smartwatches and answer 
accordingly. 
  
Q9 Are you aware that diabetic smartwatches are currently available? 
❍ Yes (1) 
❍ No (2) 
  
Q10 Have you ever used a diabetic smartwatch? 
❍ Yes (1) 
❍ No (2) 
 
Q11 Do you currently use a diabetic smartwatch to monitor your diabetes? 
❍ Yes (1) 
❍ No (2) 
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Q12 Please describe the extent to which the following factors influenced your decision to 
use or not use diabetic smartwatches to monitor your diabetes. 
  Not 
Important 
(1) 
2  3  4  5  6 Very 
Important 
(7) 
Initial 
acquisition 
cost of 
technology   
o   o   o   o   o   o   o   
Recurring 
cost of 
technology  
o   o   o   o   o   o   o   
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Usefulness  
o   o   o   o   o   o   o   
Ease of use  
o   o   o   o   o   o   o   
Knowledge 
of how to 
use 
technology  
o   o   o   o   o   o   o   
  
 Q13  Please describe the extent to which the following factors influenced your decision 
to use or not use diabetic smartwatches to monitor your diabetes. 
  Not 
Important 
(1) 
2  3  4  5 6 Very 
Important 
(7) 
How others 
would 
perceive 
me when 
I'm wearing 
the 
technology  
o   o   o   o   o   o   o   
Knowledge 
of where to 
purchase 
technology  
o   o   o   o   o   o   o   
Financial 
support 
from 
insurance  
o   o   o   o   o   o   o   
51 
Financial 
support 
from 
government 
programs  
o   o   o   o   o   o   o   
  
Q14 How effective do you believe diabetic smartwatches are at monitoring your 
diabetes? 
❍ Not at all effective (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Effective (7) 
  
Q15 How much do you trust diabetic smartwatches to monitor your diabetes? 
❍ Not at all (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Much (7) 
 
Q16 What is your overall attitude toward diabetic smartwatches? 
❍ Very Negative (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Positive (7) 
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Q17 How likely would you be to use diabetic smartwatches in the future? 
❍ Very Unlikely  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Likely (7) 
  
Q18 How probable would you be to use diabetic smartwatches in the future? 
❍ Not Probable  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Probable (7) 
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Q19 
SMART SOCKS 
Smart socks utilize sensors that detect changes in temperature to determine whether there 
is inflammation in your feet, a problem that people with diabetes can experience. Users 
can connect to a mobile app to receive accurate information and alerts about possible 
injuries such as foot ulcers. 
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 Q20 
DIRECTIONS:  
Please consider the following questions about smart socks and answer accordingly. 
  
Q21 Are you aware that smart socks are currently available? 
❍ Yes (1) 
❍ No (2) 
 
Q22 Have you ever used smart socks? 
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❍ Yes (1) 
❍ No (2) 
  
 
Q23 Do you currently use smart socks to monitor your diabetes? 
❍ Yes (1) 
❍ No (2) 
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Q24  Please describe the extent to which the following factors influenced your decision to 
use or not use smart socks to monitor your diabetes. 
  Not 
Important 
(1) 
2  3  4 5 6 Very 
Important 
(7) 
Initial 
acquisition 
cost of 
technology   
o   o   o   o   o   o   o   
Recurring 
cost of 
technology  
o   o   o   o   o   o   o   
Usefulness  
o   o   o   o   o   o   o   
Ease of use  
o   o   o   o   o   o   o   
Knowledge 
of how to 
use 
technology  
o   o   o   o   o   o   o   
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 Q25  Please describe the extent to which the following factors influenced your decision 
to use or not use smart socks to monitor your diabetes. 
  Not 
Important 
(1) 
2  3  4 5  6 Very 
Important 
(7) 
How others 
would 
perceive 
me when 
I'm wearing 
the 
technology  
o   o   o   o   o   o   o   
Knowledge 
of where to 
purchase 
technology  
o   o   o   o   o   o   o   
Financial 
support 
from 
insurance  
o   o   o   o   o   o   o   
Financial 
support 
from 
government 
programs  
o   o   o   o   o   o   o   
 
Page Break   
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Q26 How effective do you believe smart socks are at monitoring your diabetes? 
❍ Not at all effective  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Effective (7) 
  
Q27 How much do you trust smart socks to monitor your diabetes? 
❍ Not at all  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very much (7) 
  
Q28 What is your overall attitude toward smart socks? 
❍ Very Negative  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Positive (7) 
  
Q29 How likely would you be to use smart socks in the future? 
❍ Very Unlikely  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Likely (7) 
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Q30 How probable would you be to use smart socks in the future? 
❍ Not Probable  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Probable (7) 
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Q31 
CONTINUOUS GLUCOSE MONITORS 
A continuous glucose monitor (CGM) works through a tiny sensor inserted under 
your skin, usually on your belly or arm. The sensor measures the glucose found in 
the fluid between your cells. The sensor tests glucose every few minutes and a 
transmitter wirelessly sends the information to a monitor. 
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Q32 
DIRECTIONS:  
Please consider the following questions about continuous glucose monitors (CGM) 
and answer accordingly. 
  
Q33 Are you aware that continuous glucose monitors are currently available? 
❍ Yes (1) 
❍ No (2) 
  
Q34 Have you ever used a continuous glucose monitor? 
❍ Yes (1) 
❍ No (2) 
  
Q35 Do you currently use a continuous glucose monitor to monitor your diabetes? 
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❍ Yes (1) 
❍ No (2) 
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Q36 Please describe the extent to which the following factors influenced your decision to 
use or not use continuous glucose monitor to monitor your diabetes. 
  Not 
Important 
(1) 
2  3 4  5 6 Very 
Important 
(7) 
Initial 
acquisition 
cost of 
technology   
o   o   o   o   o   o   o   
Recurring 
cost of 
technology  
o   o   o   o   o   o   o   
Usefulness  
o   o   o   o   o   o   o   
Ease of use  
o   o   o   o   o   o   o   
Knowledge 
of how to 
use 
technology  
o   o   o   o   o   o   o   
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 Q37 Please describe the extent to which the following factors influenced your decision to 
use or not use continuous glucose monitor to monitor your diabetes. 
  Not 
Important 
(1) 
2  3 4  5  6  Very 
Important 
(7) 
How others 
would 
perceive 
me when 
I'm wearing 
the 
technology  
o   o   o   o   o   o   o   
Knowledge 
of where to 
purchase 
technology  
o   o   o   o   o   o   o   
Financial 
support 
from 
insurance  
o   o   o   o   o   o   o   
Financial 
support 
from 
government 
programs  
o   o   o   o   o   o   o   
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Q38 How effective do you believe continuous glucose monitors are at monitoring your 
diabetes? 
❍ Not at all effective (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very effective (7) 
  
 Q39 How much do you trust continuous glucose monitors to monitor your diabetes? 
❍ Not at all (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very much (7) 
  
Q40 What is your overall attitude toward continuous glucose monitors? 
❍ Very Negative  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Positive (7) 
  
Q41 How likely would you be to use continuous glucose monitors in the future? 
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❍ Very Unlikely  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Likely (7) 
  
 
 
 
 
Q42 How probable would you be to use continuous glucose monitors in the future? 
❍ Not Probable  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Probable (7) 
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Q43 
INSULIN PUMPS 
Insulin pumps easily distribute insulin dosages in two ways: continuous or rapid. 
The dosages are separated into basal (delivered throughout 24 hours to maintain 
normal glucose levels between meals and overnight) and bolus (to assist with levels 
after consuming carbohydrates). Doses are delivered through a flexible plastic tube. 
With the aid of a small needle, this tube is inserted through the skin into the fatty 
tissue and is taped in place. The device mimics the body's normal release of insulin. 
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Q44 
DIRECTIONS:  
Please consider the following questions about insulin pumps and answer 
accordingly. 
   
Q45 Are you aware that insulin pumps are currently available? 
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❍ Yes (1) 
❍ No (2) 
  
Q46 Have you ever used insulin pumps? 
❍ Yes (1) 
❍ No (2) 
  
Q47 Do you currently use insulin pumps to control your diabetes? 
❍ Yes (1) 
❍ No (2) 
  
Page Break   
 
 
Q48 Please describe the extent to which the following factors influenced your decision to 
use or not use insulin pumps to control your diabetes. 
  Not 
Important 
(1) 
2  3  4 5 6 Very 
Important 
(7) 
Initial 
acquisition 
cost of 
technology   
o   o   o   o   o   o   o   
Recurring 
cost of 
technology  
o   o   o   o   o   o   o   
Usefulness  
o   o   o   o   o   o   o   
Ease of use  
o   o   o   o   o   o   o   
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Knowledge 
of how to 
use 
technology  
o   o   o   o   o   o   o   
  
 
 
 
 
 
 
 
 
 Q49 Please describe the extent to which the following factors influenced your decision to 
use or not use insulin pumps to control your diabetes. 
  Not 
Important 
(1) 
2  3 4  5  6  Very 
Important 
(7) 
How others 
would 
perceive 
me when 
I'm wearing 
the 
technology  
o   o   o   o   o   o   o   
Knowledge 
of where to 
purchase 
technology  
o   o   o   o   o   o   o   
Financial 
support 
from 
insurance  
o   o   o   o   o   o   o   
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Financial 
support 
from 
government 
programs  
o   o   o   o   o   o   o   
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Q500 How effective do you believe insulin pumps are at controlling your diabetes? 
❍ Not at all effective  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very effective (7) 
  
Q51 How much do you trust insulin pumps to control your diabetes? 
❍ Not all all  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very much (7) 
 
  
Q52 What is your overall attitude toward insulin pumps? 
❍ Very Negative  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Much (7) 
   
Q53 How likely would you be to use insulin pumps in the future? 
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❍ Very Unlikely  (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Likely (7) 
   
 
 
 
 
 
 
Q54 How probable would you be to use insulin pumps in the future? 
❍ Not Probable (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Very Probable (7) 
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Q55 Now please honestly answer the following questions about yourself, in general.  
  
Q56 I'm self conscious about the way I look. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
 
Q57 I'm concerned about what other people think of me. 
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❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
  
Q58 I care a lot about what my friends think of me. Select 4 to show you're paying 
attention. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
 
 
Q59 If you want something done right, you've got to do it yourself. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
  
 Q60 In the long run the only person you can count on is yourself. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
 
Q61 Diabetes is a health issue that is personally relevant to me. 
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❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
  
Q62 I am very involved with diabetes as a health issue. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
Page Break   
 
 
 
 
Q63 I buy things without thinking. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
   
Q64 I consider myself an impulse purchaser. 
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❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
 
Q65 I'd rather take risks than be overly cautious. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7) 
  
Q66 I love to take risks even when there is a small chance I could get hurt. 
❍ Strongly Disagree (1) 
❍ 2 
❍ 3 
❍ 4 
❍ 5 
❍ 6 
❍ Strongly Agree (7)  
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Q67 These last sets of questions are for classification purposes only.  Your responses will 
be completely anonymous. 
   
 
Q68 In general, would you say your health is: 
❍ Excellent 
❍ Very Good 
❍ Good 
❍ Fair 
❍ Poor 
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Q69 When thinking about all of the diabetes-related symptoms that you may have 
experienced during the past 4 weeks, please indicate the option that best describes how 
your symptoms overall have been: 
❍ No symptoms 
❍ Mild symptoms 
❍ Moderate symptoms 
❍ Severe symptoms   
 
Q70 Have you had your hemoglobin A1c (HbA1c) checked in the last six months? 
❍ Yes (1) 
❍ No (2) 
  
 Q71 Do you know what your hemoglobin A1c (HbA1c) level was the last time it was 
checked? 
❍ Yes (1) 
❍ No (2) 
   
Display This Question: 
If Do you know what your hemoglobin A1c (HbA1c) level was the last time it 
was checked? = Yes 
  
Q71.1 What was the measured level? (for example: 7.0) 
______________________________________________________________
__ 
  
 Q72 How many times a day on average do you prick your finger to monitor your blood 
glucose? 
  
❍ 0 times a day (1) 
❍ 1-2 times a day (2) 
❍ 3-4 times a day (3) 
❍ 5-6 times a day (4) 
❍ 7 or more times a day (5) 
  
Q73 Do you use any type of non-wearable technology to help you with your diabetes? 
❍ Yes (1) 
❍ No (2) 
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Display This Question: 
If Do you use any type of non-wearable technology to help you with your 
diabetes? = Yes 
  
Q73.3 Please list all types of non-wearable technologies you use to help with your 
diabetes. 
________________________________________________________________ 
  
Q74 Do you use any type of wearable technology to monitor any aspect of your health 
other than diabetes? 
❍ Yes (1) 
❍ No (2) 
  
Display This Question: 
If Do you use any type of wearable technology to monitor any aspect of your 
health other than diabetes? = Yes 
  
Q74.1 Please list all types of wearable technologies you use to monitor any aspect 
of your health other than diabetes. 
________________________________________________________________ 
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 Q75 How many years ago were you first diagnosed with diabetes? (for example: 5) 
________________________________________________________________ 
  
 
 
 
 
 
 
 
 
 
Q76 Does your family have a history of diabetes? 
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❍ Yes (1) 
❍ No (2) 
 
Q77 What medications do you regularly take for your diabetes diagnosis? Select all that 
apply. 
▢ oral medication  (1) 
▢ insulin injection once a day  (2) 
▢ insulin injections multiple times a day  (3) 
▢ continuous delivery system for insulin  (4) 
▢ other injectables  (5) 
▢ none of the above  (6) 
  
Q78 Do you have any of the following health issues in addition to diabetes? Select all 
that apply. 
▢ heart disease  (1) 
▢ hypertension  (2) 
▢ neuropathy  (3) 
▢ diabetic foot  (4) 
▢ none of the above  (5) 
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Q79 What is the highest level of education you have completed?  
❍ Some high school (1) 
❍ High school graduate or the equivalent (GED) (2) 
❍ Some college (3) 
❍ Trade/technical/vocational training (4) 
❍ College graduate (5) 
❍ Some postgraduate work (6) 
❍ Post graduate degree (7) 
  
Q80 What is your biological sex? 
 
❍ Male (1) 
❍ Female (2) 
❍ Prefer not to answer (3) 
  
Q81 How old are you? (for example: 23) 
________________________________________________________________  
  
Q82 What is your ethnicity? 
❍ White/Caucasian (1) 
❍ Hispanic or Latino (2) 
❍ Native American or American Indian (3) 
❍ Asian/Pacific Islander (4) 
❍ African-American/Black (5) 
❍ Other (6) 
 
Q83 My annual income from all sources is: 
❍ Less than 29,999 (1) 
❍ 30,000-39,999 (2) 
❍ 40,000-49,999 (3) 
❍ 50,000-59,999 (4) 
❍ 60,000-69,999 (5) 
❍ 70,000-79,999 (6) 
❍ 80,000-89,999 (7) 
❍ 90,000-99,999 (8) 
❍ 100,000 and above (9) 
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Q84 Are you married? 
❍ Yes (1) 
❍ No (2) 
  
Q85 Do you have children? 
❍ Yes (1) 
❍ No (2) 
  
Q86 What is your height? (in feet and inches, for example: 5'7") 
________________________________________________________________ 
   
Q87 What is your weight? (for example: 162 pounds) 
________________________________________________________________ 
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Appendix B 
RECRUITMENT EMAIL 
 
Hello. 
 
My name is Ashna Sethi and I am undergraduate student working with Dr. Christopher 
Newman at University of Mississippi. We are conducting a research study about 
diabetics’ quality of life with or without current use of technology along with future 
intentions. I am emailing to ask if you would like to take about 15 minutes or less to 
complete a survey for this research project. Participation is completely voluntary and 
your answers will be anonymous.  
 
The purpose of this research is to determine how diabetics use, if they do, technology. 
We want to know how diabetics use wearable technology to assist their diabetic diagnosis 
in enhancing their quality of life. You will take a survey that asks about your current and 
future intentions to use technology to improve your quality of life as a diabetic. The latter 
part of the survey are demographics –age, education, and income. You will not be asked 
for your name or any other identifying information.  
 
There are no associated risks with taking this survey. In addition to contributing to our 
knowledge about consumer behavior, you will be paid $3 for your successful completion 
of the survey.  
 
You do not have to take part in this study. Whether or not you choose to participate or to 
withdraw will not cause you to lose any benefits to which you are entitled. Inducements, 
if any, will be prorated based on the amount of time you spent taking the survey. The 
researchers may terminate your participation in the study without regard to your consent 
and for any reason, such protecting your safety and protecting the integrity of the 
research data. If the researcher terminates your participation, any inducements to 
participate will be prorated based on the amount of time your spent on the study. 
 
This study has been reviewed by The University of Mississippi’s Institutional Review 
Board (IRB). If you have any questions, concerns, or reports regarding your rights as a 
participant of research, please contact the IRB at (662) 915-7482 or irb@olemiss.edu.  
 
If you are interested, please click on the link for the survey. 
 DISCLAIMER: I have read and understand the above information. By completing 
the survey, I consent to participate in this study. I have been given a copy of this form. I 
have had an opportunity to ask questions, and I have received answers. I consent to 
participate in this study. Furthermore, I also affirm that the experimenter explained the 
study to me and told me about the study’s risks as well as my right to refuse to participate 
and to withdraw.  
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If you have any questions, comments, or concerns, please feel free to reach out to me at 
asethi@go.olemiss.edu.  
 
Thank you in advance. 
 
Ashna Sethi 
Undergraduate Student 
University of Mississippi 
 
